The Forsyth Institute   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (1910)

Organization Overview

First Clinical Trial
1999
NCT01098448
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

The Forsyth Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gingivitis (Phase 2)

Inflammation (Phase 2)

Periodontal Diseases (Phase 2)

Periodontitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 10